141 related articles for article (PubMed ID: 38153518)
1. Association between social background and implementation of postoperative adjuvant chemotherapy for older patients undergoing curative resection of colorectal cancers, sub-analysis of the HiSCO-04 study.
Bekki T; Shimomura M; Saito Y; Nakahara M; Adachi T; Ikeda S; Shimizu Y; Kochi M; Ishizaki Y; Yoshimitsu M; Takakura Y; Shimizu W; Sumitani D; Kodama S; Fujimori M; Oheda M; Kobayashi H; Akabane S; Yano T; Ohdan H
Int J Colorectal Dis; 2023 Dec; 39(1):11. PubMed ID: 38153518
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes of patients with stage III colorectal cancer aged ≥ 80 years who underwent curative resection: the HiSCO-04 prospective cohort study.
Mochizuki T; Shimomura M; Nakahara M; Adachi T; Ikeda S; Saito Y; Shimizu Y; Kochi M; Ishizaki Y; Yoshimitsu M; Takakura Y; Shimizu W; Sumitani D; Kodama S; Fujimori M; Oheda M; Kobayashi H; Akabane S; Yano T; Ohdan H
Int J Clin Oncol; 2024 Feb; 29(2):159-168. PubMed ID: 38099976
[TBL] [Abstract][Full Text] [Related]
3. A prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 study.
Okuda H; Shimomura M; Ikeda S; Nakahara M; Miguchi M; Ishizaki Y; Saitoh Y; Toyota K; Sumitani D; Shimizu Y; Takakura Y; Shimizu W; Yoshimitsu M; Kodama S; Fujimori M; Oheda M; Kobayashi H; Ohdan H;
Cancer Chemother Pharmacol; 2023 Apr; 91(4):317-324. PubMed ID: 36947210
[TBL] [Abstract][Full Text] [Related]
4. Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer.
Kanehara R; Goto A; Watanabe T; Inoue K; Taguri M; Kobayashi S; Imai K; Saito E; Katanoda K; Iwasaki M; Ohashi K; Noda M; Higashi T
J Diabetes Investig; 2022 Oct; 13(10):1771-1778. PubMed ID: 35588283
[TBL] [Abstract][Full Text] [Related]
5. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study.
Yamano T; Yamauchi S; Kimura K; Babaya A; Hamanaka M; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Tomita N; Sugihara K;
Eur J Cancer; 2017 Aug; 81():90-101. PubMed ID: 28622612
[TBL] [Abstract][Full Text] [Related]
6. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
Madbouly KM; Hussein AM; Zeid A
Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
[TBL] [Abstract][Full Text] [Related]
8. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
[TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant chemotherapy in patients with curatively resected stage IV colorectal cancer.
Kobayashi H; Kotake K; Sugihara K;
Medicine (Baltimore); 2015 May; 94(17):e696. PubMed ID: 25929899
[TBL] [Abstract][Full Text] [Related]
11. A Study on the Tolerability of Capecitabine plus Oxaliplatin as Adjuvant Chemotherapy.
Nakanishi M; Kuriu Y; Murayama Y; Arita T; Kosuga T; Morimura R; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Ichikawa D; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2016 Apr; 36(4):1851-4. PubMed ID: 27069169
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study.
Quipourt V; Jooste V; Cottet V; Faivre J; Bouvier AM
J Am Geriatr Soc; 2011 Apr; 59(4):694-8. PubMed ID: 21438864
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
Luvira V; Satitkarnmanee E; Pugkhem A; Kietpeerakool C; Lumbiganon P; Pattanittum P
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012814. PubMed ID: 34515993
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
[TBL] [Abstract][Full Text] [Related]
16. Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
Chen TC; Jeng YM; Liang JT
J Formos Med Assoc; 2021 May; 120(5):1194-1201. PubMed ID: 33023787
[TBL] [Abstract][Full Text] [Related]
17. Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
Pan Z; Peng J; Lin J; Chen G; Wu X; Lu Z; Deng Y; Zhao Y; Sui Q; Wan D
Cancer Commun (Lond); 2018 May; 38(1):29. PubMed ID: 29843800
[TBL] [Abstract][Full Text] [Related]
18. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer.
Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
Br J Cancer; 2006 Jun; 94(12):1833-6. PubMed ID: 16721360
[TBL] [Abstract][Full Text] [Related]
19. Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection.
Tsai WS; Hsieh PS; Yeh CY; Chiang JM; Tang R; Chen JS; Changchien CR; Wang JY
Int J Clin Oncol; 2013 Apr; 18(2):242-53. PubMed ID: 22262452
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of Postoperative Adjuvant Chemotherapy in the Population Aged 75 Years and Older with Stage II-III Colorectal Cancer: A Retrospective Multi-Center Cohort Study.
Liu L; Pang X; Zhao K; Chen Y; Li Y; You R; Xu T; Liu M; Wu L; Li Z; Pu H
Int J Gen Med; 2023; 16():3311-3322. PubMed ID: 37554705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
